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CHAPTER 1
Introduction
Muscle Metaboreflex: the Afferent Arm
Skeletal muscle is extensively innervated with afferent sensory nerve fibers
which communicate information to the central nervous system (CNS) regarding its
relative state or condition. Skeletal muscle afferents refer to signals emerging from
encapsulated skeletal muscle structures such as muscle spindles and Golgi tendon
organs (i.e., proprioceptors) which relay proprioceptive information (e.g., muscle
position, tension and rate of length change) to the CNS by way of group I and II afferent
fibers.

In addition, skeletal muscle afferents relay “chemical” and “mechanical”

information to the CNS regarding the current state of its interstitial chemical milieu and
physical stress associated with muscle work (20; 79).

These types of signals are

collectively and aptly referred to as ergoceptive information emerging from
encapsulated, free nerve endings within skeletal muscle (i.e., ergoceptors) and are
carried by neurons classified as group III and IV afferent fibers (76).
In a classic series of human experiments by Alam and Smirk (4; 5), they
discovered that exercise during complete circulatory occlusion (i.e., ischemic exercise)
evoked marked elevations in blood pressure and heart rate (HR) that were sustained
upon cessation of the exercise so long as the blood flow to the exercising muscle
remained arrested.

The absence of arterial inflow to and venous outflow from the

muscle effectively eliminated the potential for endocrine communication between the
muscle and the CNS. As a result, they concluded that the observed reflex response
must be neurogenic and that the stimulus initiating and sustaining the reflex was the
accumulation of metabolites within the muscle. Although the findings of their initial
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experiments were purely serendipitous, their studies are regarded as the pioneering
work demonstrating the presence of such a ‘muscle metabolite’ reflex. Following up on
this work, Asmussen and Nielsen (11) produced similar results in dynamic exercising
humans, however in addition to suggesting muscle chemoreceptors they also implicated
muscle mechanoreceptors as the potential source of the reflex pressor response.
Subsequent animal experiments by Coote and Perez-Gonzalez (25) and McCloskey
and Mitchell (102) offered insights into the afferent arm of this reflex as they
demonstrated the capacity of group III and IV ergoceptive fibers to elicit a reflex pressor
response (i.e., increase in arterial blood pressure), while in addition they showed that
the group I and II proprioceptive afferents played no role in evoking such a reflex.
Further animal studies discovered multiple stimulus modalities for group III and IV
afferents. In general, group III afferents were shown to be primarily responsive to the
mechanical stresses generated during muscle contraction (e.g., increases in tissue
pressure) (63; 77; 78; 125), while group IV afferents were found to be acutely sensitive
to metabolites (e.g., hydrogen ion, lactate, potassium ion, diprotonated phosphate and
ATP) which accumulate within underperfused active skeletal muscle (34; 61; 86; 95;
128; 145; 146; 157). In support of these findings, the anatomical location of ergoceptive
afferents has been visualized via electron microscopy revealing, in general, that group
III afferent nerve endings are intimately associated with the connective tissue elements
of skeletal muscle, whereas group IV afferent nerve endings emanate from small blood
vessels within the muscle (160).

Adding a layer of complexity, many studies have

demonstrated that “mechanoreceptors” can be sensitized by muscle metabolites
developed during ischemia and that “metaboreceptors” are sensitive to mechanical
stimulation (77; 85; 86; 127; 129). Nonetheless, as a result of these findings, group III
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and IV afferents were classified as mechanoreceptors and metaboreceptors,
respectively. It therefore became evident that the metabolically, chemo-sensitive reflex
pressor response suggested by Alam and Smirk and other investigators, now referred to
as the muscle metaboreflex, was indeed initiated by group III and group IV afferents.
Muscle Metaboreflex: the Efferent Arm
Following up on the early work elucidating the afferent structure and function of
the muscle metaboreflex, a litany of experiments has been performed in humans and in
animals with the intent of investigating its efferent arm. Early investigators not only
observed reflex-induced pressor responses, reflex increases in other hemodynamic
(e.g., HR and pulmonary (e.g., ventilation) parameters were additionally reported in their
studies (5; 11; 24; 102). In order to study the efferent mechanisms of the muscle
metaboreflex, focus was shifted to measuring and analyzing the hemodynamic
outcomes of muscle metaboreflex-induced increases in sympathetic outflow from the
CNS. Incidentally, the mechanisms of integration in the control center of this reflex (i.e.,
the brainstem) are not well known. A very common approach developed to elicit and
study the reflex is the induction of skeletal muscle ischemia (by way of vascular
occlusion) prior to or during a bout of static or dynamic exercise (3; 4; 11; 24; 26; 31;
74; 116; 144; 163).

Data from these types of experiments not only supported the

findings of earlier studies, but also expanded the list of muscle metaboreflex-induced
efferent responses. Along with increases in mean arterial pressure (MAP), HR and
cardiac output (CO), the muscle metaboreflex has additionally been shown to increase
stroke volume (SV) (144), right atrial pressure (RAP) (140), ventricular performance (27;
34; 116; 138; 151; 152) and sympathetic nerve activity (SNA) (114; 158; 159). Even
though there are innumerable observations of reflex-induced increases in these
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cardiovascular parameters during exercise, most data suggest that the muscle
metaboreflex only presents its negative feed-back influence over cardiovascular control
when skeletal muscle is faced with a mismatch between oxygen supply and demand
(i.e., during ischemia). As muscle metabolites normally accumulate as a result of a
decrease in perfusion to the working muscle, the muscle metaboreflex has often been
regarded as a flow-sensitive reflex (120). In fact, Wyss et al. (163) demonstrated the
existence of a threshold for such a “flow error signal” while studying canines
dynamically exercising at varying work intensities. In general, as the intensity of the
workload increased hindlimb perfusion progressively fell and the margin for error in
muscle blood flow approached zero. In contrast, data from Sheriff et al. (143) showed
that it is not a reduction in flow per se that triggers the accumulation of muscle
metabolites, rather it is a reduction in oxygen delivery to the muscle. In any event, there
is strong evidence that the muscle metaboreflex is tonically active during higher
intensity (moderate to severe) exercise in dynamically exercising canines (14; 120;
163). Furthermore, in disease states where perfusion to skeletal muscle is impaired,
such as in heart failure or peripheral arterial stenosis, the muscle metaboreflex may
indeed be active even during lower intensity (mild to moderate) dynamic exercise (59;
94).

It is generally believed that cardiovascular responses to mild exercise are

controlled by feed-forward CNS efferent commands (i.e., central command) and
principally modulated by the negative feed-back influence of the arterial baroreflex.
However, there are data implicating muscle metaboreflex influence over cardiovascular
function during mild exercise as well (2; 6; 135).

Very recently, Amann et al. (6)

provided evidence in humans that increases in MAP, CO, HR and ventilatory rate during
mild exercise might be, in part, controlled by a tonically active muscle metaboreflex.
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Muscle Metaboreflex Activation During and Following the Cessation of Exercise
In an attempt to separate the previously reported efferent responses of the
muscle metaboreflex from the influence of central command and the baroreflex,
investigators sought to “isolate” the reflex during the recovery from exercise.

This

technique, first employed by Alam and Smirk, was designed to induce ischemia (by way
of vascular occlusion) in the muscle immediately upon or before the cessation of the
exercise and is commonly referred to as post-exercise muscle ischemia (PEMI) (16; 19;
31; 45; 102; 132). As expected, the cardiovascular parameters previously reported to
be augmented by muscle metaboreflex activation during ischemic exercise are
sustained during the recovery from exercise so long as the imposed circulatory
occlusion is sustained, or PEMI (4; 19; 30; 45; 115; 133; 144). Curiously though, there
is one notable exception. The vast majority of studies sustaining muscle metaboreflex
activation during PEMI report a decline in HR during this maneuver while the pressor
response is sustained (5; 16; 31; 45; 133; 144; 159). With HR precipitously declining
towards resting levels during PEMI, with a time-course similar to normal recovery from
exercise, muscle metaboreflex control over the chronotropic function of the heart was
drawn into question (46; 133; 134; 159). Moreover, as CO is directly proportional to HR,
questions immediately arose regarding the mechanism(s) sustaining the pressor
response observed during PEMI in the absence of a sustained elevation in HR. In the
absence of a CO component, the only other mechanism available to sustain an
elevation in MAP during PEMI would be peripheral vasoconstriction. Indeed, previous
studies both support (19; 30-32; 123; 132; 144) and refute (16; 32; 123) any role for CO
in mediating the pressor response during PEMI. Clearly, the role of CO vs. peripheral
vasoconstriction in mediating the pressor response during PEMI is debatable, and it

6
remains a controversial issue yet to be resolved.
In contrast to PEMI, it is well documented that during submaximal ischemic
exercise, the pressor response occurs primarily via increased CO with little, if any,
peripheral vasoconstriction (38; 59; 83; 116; 131; 140; 163). Interestingly, many studies
have demonstrated a “switch” from a flow-mediated rise in MAP during exercise to a
vasoconstriction-mediated pressor response, when the reflex increase in CO is
attenuated. For example, Sheriff et al. (140) and Ichinose et al. (68) demonstrated
substantial decreases in peripheral vascular conductance (i.e., increases in peripheral
vasoconstriction) when they abolished the metaboreflex-induced increase in CO during
mild, dynamic exercise via ventricular pacing with β1-adrenergic blockade or mechanical
occlusion of the vena cavae, respectively.

In addition, Augustyniak et al. (14)

demonstrated a shift from CO to peripheral vasoconstriction when workload approached
maximal levels and further increases in CO were limited.

Moreover, studies from

O’Leary and colleagues (59) and others (29) have demonstrated this same shift from
CO to peripheral vasoconstriction in heart failure, a condition in which CO is attenuated
as a result of impaired inotropic and/or chronotropic function. Thus, it appears that
whether or not increases in CO or peripheral vasoconstriction is utilized as a means to
raise MAP with metaboreflex activation during dynamic exercise is dependent on the
ability to increase CO.
Very recently, Sala-Mercado et al. (136) reported attenuated metaboreflexinduced chronotropic, inotropic and lusitropic responses in hypertension (HTN) during
submaximal dynamic exercise.

Inasmuch as increases in CO with metaboreflex

activation were markedly reduced, the rise in MAP was attenuated as well. The pressor
response likely resulted from a combination of the small increase in CO and enhanced
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peripheral vasoconstriction. Other studies investigating muscle metaboreflex function in
HTN are limited, and the overall findings are equivocal: exaggerated (35; 52; 89; 106;
107; 139; 148) vs. attenuated (126) metaboreflex responses.

Moreover, the

mechanisms sustaining the muscle metaboreflex-mediated pressor response during
PEMI in HTN are virtually unknown.
Muscle Metaboreflex Activation and Ventricular Performance
It is well known that CO is impaired in heart failure and that exercise in this
condition results in muscle metaboreflex-mediated pressor responses that are
principally generated by increases in peripheral vasoconstriction, not CO. Hammond et
al. (59) concluded that the observed peripheral vasoconstriction in heart failure was
mediated by exaggerated SNA (as indexed by elevated plasma norepinephrine (NE)
levels) and elevations in other vasoactive hormones such as arginine vasopressin
(AVP) and renin.

Though one of the hallmarks of heart failure is heightened

sympathoactivation at rest, this study additionally reported significant increases in SNA
(and vasoactive hormones) with muscle metaboreflex activation during exercise. The
peripheral vasculature is not the sole efferent target of this reflex-induced elevation in
SNA as there is marked sympathoactivation of the heart as well leading to increases in
its chronotropic and inotropic functions as previously discussed. Inasmuch as vascular
smooth muscle cells of coronary blood vessels express alpha adrenergic receptors,
they too are potential efferent targets of this elevated sympathetic outflow. An increase
in SNA to the heart can activate vascular smooth muscle α1-adrenergic receptors
resulting in vasoconstriction of the coronary arteries (27; 57; 108). On the other hand,
an increase in SNA to the heart will also increase the work done by the heart which can
in turn lead to the generation of local metabolites that induce a coronary vasodilation.
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Another potential mechanism of coronary vasodilation is the feed-forward sympathetic
activation of coronary β2-adrenergic receptors (49). Overall, coronary vasomotor tone
appears to be principally modulated by local metabolic vasodilation (i.e., active
hyperemia) and sympathetically-mediated α1-adrenergic vasoconstriction (37; 40; 156).
The balance of these antagonistic mechanisms will ultimately determine the degree of
perfusion of the heart, or coronary blood flow (CBF). At rest, the heart is an oxygen
sink, as it extracts upwards of 80% of the oxygen in arterial blood (37; 40). An increase
in workload on the heart (e.g., the onset of exercise) increases myocardial oxygen
demand, however this poses a significant challenge to the heart as it is incapable of
extracting a significantly greater fraction of oxygen from the very blood it strips 80%
from at rest. Therefore, a coronary vasodilatory reserve is of paramount physiological
importance to the heart, as an increase in CBF serves as the primary mechanism to
increase the supply of oxygen available to the heart. An increase in perfusion pressure
to the heart will lead to an increase in oxygen delivery but will also initiate a myogenic
autoregulatory vasoconstriction.

However, this negative feed-back mechanism is

counteracted by a metabolic coronary vasodilation when the workload of the heart
significantly increases (e.g., during moderate or severe exercise) permitting marked
increases in CBF.
There are reports, however, of an α1-adrenergic constrictor tone which reduces
this coronary vasodilatory reserve during exercise. Gwirtz et al. (57) demonstrated that
as workload increases, there is progressively greater α1-adrenergic tone which restrains
the metabolic coronary vasodilation.

Ansorge et al. (10) examined the potential

contribution of the muscle metaboreflex to this α-adrenergic-mediated coronary
vasoconstriction phenomenon by measuring CBF and coronary vascular conductance
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(CVC) during dynamic exercise in canines. During severe exercise, they reported an
attenuated reflex increase in CBF along with a significant reduction in CVC due to
accentuated coronary vasoconstriction with muscle metaboreflex activation.

They

concluded that the muscle metaboreflex-induced rise in SNA to the heart functionally
vasoconstricts the coronary vasculature, thereby attenuating the rise in CBF. Thus,
during strenuous exercise any coronary metabolic vasodilation induced by the increase
in myocardial performance is counteracted by an increase in sympathetically-mediated
coronary vasoconstriction.

These findings, along with the data demonstrating

heightened SNA in canines with heart failure at rest and during exercise with muscle
metaboreflex activation, suggested a possible mechanism for the impaired CO
responses observed in heart failure.

Indeed, Ansorge et al. (9) demonstrated a

significant reduction in CVC leading to an attenuated rise in CBF with muscle
metaboreflex activation during mild and moderate exercise in animals with heart failure.
They suggested that the marked coronary vasoconstriction observed in heart failure
with muscle metaboreflex activation was as a potential mechanism responsible for the
reduced ability to raise CO in this condition. O’Leary et al. (118) reported another
potential mechanism for this impaired CO response with muscle metaboreflex activation
in heart failure during exercise when they demonstrated a concomitant reduction in SV.
A reduced SV with muscle metaboreflex activation in heart failure suggested impaired
ventricular function and/or preload and, in fact, subsequent studies from O’Leary and
colleagues (137) reported impaired ventricular contractility with muscle metaboreflex
activation in heart failure during exercise. Furthermore, Gwirtz et al. (57) and O’Leary et
al. (119) additionally reported an increase cardiac performance and CO, respectively, as
a result of an abolition of coronary vasoconstriction following α-adrenergic blockade
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during exercise.

Coutsos et al. recently demonstrated that during mild, dynamic

exercise sympathetically-mediated restraint of coronary vasodilation (the extent
determined by α-adrenergic blockade) during muscle metaboreflex activation impairs
increases in left ventricular contractility in normal (27) and heart failure (28) animals.
Collectively, these data suggest that a sympathetically-mediated restraint of metabolic
coronary vasodilation during periods of increased myocardial metabolic demand can
limit the rise in CBF and therefore further limit increases in ventricular performance and
the rise in CO as seen in heart failure.
As with heart failure, HTN is a condition in which individuals present with
exaggerated levels of SNA (8; 51; 54; 72; 97; 101; 105; 155).

Moreover, resting

coronary vasoconstriction and restrained coronary metabolic vasodilation during
submaximal dynamic exercise (presumably due to heightened SNA) has been
demonstrated in canines with renovascular HTN (55).

Sala-Mercado et al. (136)

reported attenuated metaboreflex-induced increases in ventricular function and CO in
HTN (Goldblatt 2K1C (47; 48)) during submaximal dynamic exercise. The extent to
which coronary vasoconstriction contributes to impaired ventricular function observed
during muscle metaboreflex activation in HTN is unknown.
Summary/Dissertation Aims
Skeletal muscle ischemia during or immediately following exercise leads to the
accumulation of metabolites (e.g., lactate and proton) which activate chemoreceptive
afferents within the muscle leading to a reflex increase in sympathetic outflow
generating substantial increases in MAP, CO and HR - termed the muscle
metaboreflex. The muscle metaboreflex is generally regarded as a flow-sensitive reflex
that is elicited when skeletal muscle is faced with a mismatch between oxygen supply
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and demand, and thereby increases cardiac function in an attempt to increase perfusion
to the ischemic muscle.
Two different approaches have been employed to study this reflex. Blood flow to
the exercising muscle can be reduced prior to or during a bout of static or dynamic
exercise thereby activating the reflex during ischemic exercise. In contrast, the reflex
can be elicited by inducing ischemia in the muscle immediately before or upon
cessation of the exercise – PEMI.

When the reflex is activated during sustained

submaximal dynamic exercise, the pressor response occurs primarily via increased CO.
In contrast, during PEMI, whereas MAP remains elevated for as long as the ischemia is
maintained, HR precipitously declines towards resting levels drawing into question the
role of CO in mediating the pressor response during this period. Indeed, the role of CO
in mediating the pressor response during PEMI remains debatable.
Specific Aim (I): To determine the mechanism(s) mediating the musclemetaboreflex-induced pressor response observed during PEMI in normal
subjects.
Many studies have demonstrated a “switch” from a flow-mediated rise in MAP
during exercise to a vasoconstriction-mediated pressor response when the reflex
increase in CO is attenuated (e.g., in heart failure). It appears that whether or not
increases in CO or peripheral vasoconstriction is utilized as a means to raise MAP with
metaboreflex activation during dynamic exercise or sustain it during PEMI is dependent
on the ability to increase CO. In HTN, metaboreflex-mediated increases in CO are
markedly attenuated during mild exercise.
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Specific Aim (II): To determine the mechanism(s) mediating the musclemetaboreflex-induced pressor response observed during PEMI in hypertensive
subjects.
In heart failure, a sympathetically-mediated restraint of metabolic coronary
vasodilation with metaboreflex activation during submaximal dynamic exercise limits the
rise in CBF and therefore further limits increases in ventricular performance and the rise
in CO. In HTN, metaboreflex-mediated increases in ventricular function and CO are
markedly attenuated during mild exercise. As SNA is exaggerated in both heart failure
and HTN, it is plausible that the mechanisms mediating the attenuation of CO in HTN
with muscle metaboreflex activation are similar to those previously described in heart
failure.
Specific Aim (III): To determine if muscle metaboreflex activation during
submaximal dynamic exercise in hypertensive animals induces a sympathetic
restraint of metabolic coronary vasodilation that limits the rise in CBF and
whether this restraint of CBF further limits increases in ventricular performance.
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CHAPTER 2
Role of Cardiac Output vs. Peripheral Vasoconstriction in Mediating Muscle
Metaboreflex Pressor Responses: Dynamic Exercise vs. Post-Exercise Muscle
Ischemia
Abstract
Muscle metaboreflex activation (MMA) during submaximal dynamic exercise in
normal individuals increases mean arterial pressure (MAP) via increases in cardiac
output (CO) with little peripheral vasoconstriction. The rise in CO occurs primarily via
increases in heart rate (HR) with maintained or slightly increased stroke volume. When
the reflex is sustained during recovery (post-exercise muscle ischemia - PEMI), HR
declines yet MAP remains elevated. The role of CO in mediating the pressor response
during PEMI is controversial. In seven chronically instrumented canines, steady-state
values with MMA during mild exercise (3.2 km/h) were observed by reducing hindlimb
blood flow by ~60% for 3-5 minutes. MMA during exercise was followed by 60 s of
PEMI. Control experiments consisted of normal exercise and recovery. MMA during
exercise increased MAP, HR, and CO by 55.3 ± 4.9 mmHg, 42.5 ± 6.9 beats/min and
2.5 ± 0.4 l/min, respectively. During sustained MMA via PEMI, MAP remained elevated
and CO remained well above the normal recovery levels. Neither MMA during dynamic
exercise nor during PEMI significantly affected peripheral vascular conductance. We
conclude that the sustained increase in MAP during PEMI is driven by a sustained
increase in CO not peripheral vasoconstriction.
Introduction
Skeletal muscle ischemia during or immediately after exercise leads to the
accumulation of metabolic by-products that activate group III and IV chemosensitive
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afferents within the muscle (21; 34; 79; 86; 95; 128; 143; 145; 146; 157). Activation of
these skeletal muscle afferents causes a reflex increase in sympathetic outflow that
generates substantial increases in arterial pressure termed the muscle metaboreflex (4;
11; 24; 46; 102; 114-116; 121; 132; 133; 163). Two different approaches have been
employed to study this reflex. Blood flow to the exercising muscle can be reduced
before or during a bout of static or dynamic exercise thereby activating the reflex during
ischemic exercise (3; 4; 11; 24; 26; 31; 116; 144; 163). In contrast, the reflex can be
elicited by inducing ischemia in the muscle immediately before or upon cessation of the
exercise [a technique termed post-exercise muscle ischemia (PEMI)] (16; 19; 31; 45;
46; 102; 132; 133; 157; 161).
When the reflex is activated during sustained submaximal dynamic exercise in
normal subjects, the pressor response occurs primarily via increased cardiac output
(CO), which is driven by increased heart rate (HR) coupled with sustained or slightly
increased stroke volume (SV) (31; 68; 138; 144; 163). SV is maintained despite this
tachycardia due to both enhanced ventricular contractility (27; 30; 116; 138) and
maintained or increased ventricular filling pressure via substantial central blood volume
mobilization (140). In contrast, during PEMI, whereas mean arterial pressure (MAP)
remains elevated for as long as the ischemia is maintained, HR precipitously declines
toward resting levels with a time course similar to normal recovery, which led some to
speculate that the muscle metaboreflex has little control over the heart (4; 45; 98; 133;
158; 159; 161). With HR on the decline during the recovery from exercise with or
without PEMI, the role of CO in mediating the pressor response during PEMI remains
controversial. Indeed previous studies both support (19; 30-32; 123; 132; 144) and
refute (16; 32; 123) any role for CO in mediating the pressor response during PEMI. In
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the present study, we elicited the muscle metaboreflex during dynamic exercise and
sustained this activation during PEMI to compare the mechanisms underlying the
muscle metaboreflex-mediated pressor responses in these two distinct settings.
Methods
Experimental subjects.

Seven adult mongrel canines were selected for the

study. All animals were healthy, ~20-25 kg body weight, of either sex (4 females; 3
males), well adapted to the laboratory environment and willing to run on a motor-driven
treadmill. During experimentation, all animals exercised voluntarily and no negative
reinforcement techniques were utilized. The protocols developed and employed in the
present study were reviewed and approved by the Institutional Animal Care and Use
Committee of Wayne State University and complied with the National Institutes of
Health Guide to the Care and Use of Laboratory Animals.
Surgical procedures. Each animal was completely instrumented with chronic,
indwelling cardiovascular devices following two sterile surgical procedures: left
thoracotomy and left flank retroperitoneal surgery in that order. The animals recovered
a minimum of 10 days before the second surgery and a minimum of 7 days before the
first experiment.

During preoperative care, the animals were initially sedated with

acepromazine (0.4-0.5 mg/kg IM).

After adequate sedation, the animals were

anesthetized with a combined treatment of ketamine and diazepam (5.0 and 0.22 mg/kg
IV, respectively).

Anesthesia was maintained with isoflurane gas (1-3%) after

endotracheal intubation. In addition, the animals received preoperative administration
of cefazolin (antibiotic; 30 mg/kg IV), carprofen (analgesic; 4.0 mg/kg IV), buprenorphine
(analgesic; 0.01 mg/kg IM) and fentanyl [analgesic; 125-175 µg/h, (72h) TDD]. Before
the left thoracotomy, animals received selective intercostal nerve blockade with
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bupivacaine HCl (2.0 mg/kg SQ).

After each surgical procedure, animals received

cefazolin (30 mg/kg IV) and prophylactic cephalexin [antibiotic; 30 mg/kg (BID) PO]
therapy for the term of the experimental protocol. During the 12-hour post-operative
period, animals were closely monitored and received buprenorphine and acepromazine
(0.05 and 0.5 mg/kg IV, respectively) as needed. For the following 10 days, animals
received carprofen [4 mg/kg (OPD) PO].
In the first surgical procedure, the thoracic cavity was opened via a left
thoracotomy (4th intercostal space) approach. The pericardium was cut and reflected to
expose the heart. An ultrasonic perivascular flow probe (20PAU, Transonic Systems)
was positioned around the ascending aorta to measure CO.

Approximately 10 cm

caudal to the thoracotomy incision, an implantable telemetry blood pressure transmitter
(TA11 PA-D70, Data Sciences International) was tethered subcutaneously.

The

catheter of the transmitter was tunneled into the thoracic cavity through the 7th
intercostal space, and the tip was inserted and secured inside the left ventricle for
measuring left ventricular pressure (LVP).

For studies unrelated to the present

investigation a blood flow transducer was also placed on the left circumflex artery. The
pericardium was loosely re-approximated, the cables were tunneled subcutaneously
and exteriorized between the scapulae and the chest was closed in layers.
In the second surgical procedure, an incision was made in the left flank cranial to
the iliac crest. The abdominal aorta was exposed and an ultrasonic perivascular flow
probe (10PAA, Transonic Systems) was positioned around the terminal aorta for
measuring hindlimb blood flow (HLBF). All arterial side branches between the common
iliacs and the flow probe were ligated and severed.

In addition, two perivascular

hydraulic occluders (8-10 mm, DocXS Biomedical Products) were positioned around the
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terminal aorta (distal to the flow probe) to provide the means to incrementally reduce
HLBF. A 19-gauge polyvinyl catheter (S54-HL, Tygon, Norton) was advanced through a
ligated lumbar artery and secured into the terminal aorta cranial to the probe and
occluders to measure arterial pressure.

For studies unrelated to the current

investigation a blood flow transducer and vascular occluder were placed on the left
renal artery. The cables and vascular occluder tubing were tunneled subcutaneously
and exteriorized between the scapulae.
Data acquisition.

After complete postoperative recovery, each animal was

brought into the laboratory and allowed to roam freely and acclimate for ~15-20 min.
The animal was then directed onto the treadmill where the instrumentation was
connected to the data acquisition system (TS420, Transonic Systems Blood Flow
Meter, Gould; amplifiers, Data Science International, Telemetry System, LabScribe,
iWorx).
Experimental procedures. All animals performed both control and experimental
procedures on separate days, therefore, each animal served as its own control. The
experiments began with the animal standing unrestrained on the treadmill until all
hemodynamic data were observed to be stable (typically 5-10 min). The treadmill was
turned on and the speed was gradually increased to 3.2 km/h at 0% grade [a mild
workload for a canine (60)]. Steady state was generally reached within 3-5 min. In the
control experiment, after all variables had reached steady state during exercise, the
treadmill was abruptly stopped and post-exercise (without ischemia) hemodynamic data
were collected for 60 s while the animal was standing still. In a separate experiment,
the muscle metaboreflex was engaged via partial reductions in HLBF during mild
exercise. Once the reflex was strongly engaged, steady-state data were collected for
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60 s. The treadmill was then abruptly stopped and the occlusion was sustained for an
additional 60 s (PEMI).
Data analysis. CO, HLBF, LVP, HR and MAP data were continuously recorded
during each experiment. Other hemodynamic parameters were calculated off-line [e.g.,
SV, dP/dtmax, dP/dtmin and non-ischemic vascular conductance (NIVC)].

NIVC was

calculated as (CO - HLBF)/MAP and reflects vascular conductance of all vascular beds
except the hindlimbs. Because of technical difficulties, we were only able to obtain
LVPs from six animals. One-minute averages of steady-state data were calculated at
rest, during exercise and during metaboreflex activation. 5 s averages were computed
for both 60 s post-exercise conditions: post-exercise (without ischemia) and PEMI.
These mean values were then averaged across all animals to obtain the mean values
for the entire population of the study. Finally, the last 10 s of recovery were averaged.
Statistical analysis. Averaged responses for each animal were analyzed via twoway repeated measures ANOVA to compare hemodynamic data for time and/or
condition effects. In the event of a significant time-condition interaction, a C-matrix test
for simple effects was performed. Data are reported as means ± SE, and statistical
significance was ascribed as P < 0.05.
Results
Figure 2.1 shows the responses in MAP, CO, HR, SV and HLBF from a control
and experimental protocol in one animal. In both protocols, with the transition from rest
to exercise, there was a minimal increase in MAP and modest increases in CO and HR
concomitant with a substantial rise in HLBF. During the normal recovery from exercise,
MAP remained unchanged while CO and HR gradually fell toward resting levels. In the
experimental protocol, the muscle metaboreflex was elicited immediately following
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steady-state exercise and sustained during the post-exercise recovery period (PEMI).
Muscle metaboreflex activation during the experimental protocol led to marked
increases in MAP, CO and HR and little change in SV. During PEMI, the rise in MAP
was sustained.

Although CO and HR initially fell during the onset of PEMI, both

subsequently plateaued well above their normal recovery levels.
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Figure 2.2 shows the average values
of MAP, HR, CO and NIVC during control
and experimental procedures. The 60 s of
post-exercise recovery are plotted as 5 s
averages.

The changes in MAP, HR, CO

and NIVC from rest to exercise were not
significantly different between the control and
experimental

protocols.

metaboreflex

activation

With
during

muscle
exercise,

MAP, HR and CO increased substantially.

Figure 2.2.
Averaged time-course of
MAP, HR, CO and non-ischemic vascular
conductance (NIVC) during control (open
circles) and experimental procedures (filled
circles) in 7 animals. Data at rest are the
average values from both settings (halffilled circles). * - p<0.05.

During PEMI, the ~60 mmHg rise in MAP, which was observed with muscle
metaboreflex activation, was sustained during the entire 60 s, as every data point during
this maneuver was significantly different from control. NIVC fell during the PEMI period
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with a pattern not significantly different from during the normal recovery from exercise.
HR and CO decreased abruptly during the first 15 s of PEMI; however, both of these
variables subsequently plateaued significantly above normal recovery levels.
Figure 2.3 shows the mean hemodynamic responses during exercise and the
final 10 s of recovery with and without muscle metaboreflex activation. During the last
10 s of ischemic exercise, there were significant increases in MAP, CO, HR, dP/dtmax
and dP/dtmin compared with the data during exercise without metaboreflex activation.

Figure 2.3. Mean hemodynamic responses during exercise and the final 10
seconds of recovery with (filled bars) and without (open bars) muscle metaboreflex
activation. * - p<0.05 between normal exercise and ischemic exercise, † - p<0.05
between normal recovery from exercise (open bars) and post-exercise muscle
ischemia (PEMI) (filled bars).
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During the last 10 s of the recovery from ischemic exercise, MAP, CO, HR,
dP/dtmax and dP/dtmin were all significantly elevated compared with the values during the
normal recovery from exercise, whereas there were no significant changes in NIVC or
SV.
Discussion
Our major finding is that the mechanisms mediating muscle metaboreflexinduced increases in arterial pressure are similar both when the reflex is activated
during dynamic exercise and when the reflex is sustained during the recovery from
exercise.

In both settings, the pressor response is primarily due to a substantial

elevation in CO with little, if any, peripheral vasoconstriction. Moreover, the elevation in
CO is driven via an increased HR with a sustained SV. Inasmuch as tachycardia itself
can lead to decreases in SV (87; 162), increases in ventricular contractility likely
contribute to the sustained SV. The elevated dP/dtmax supports this conclusion. Faster
left ventricular relaxation (dP/dtmin) may also aid in the maintenance of SV by increasing
filling time.

Therefore, our data demonstrate marked muscle metaboreflex-induced

chronotropic, inotropic and lusitropic responses both when the reflex is activated during
dynamic exercise and when the reflex is sustained during recovery from exercise.
Muscle metaboreflex activation during exercise. CO versus vasoconstriction.
Muscle metaboreflex activation during exercise evokes large increases in MAP, HR and
CO (4; 5; 39; 104; 115; 116; 163). However, the relative roles of CO versus peripheral
vasoconstriction in this pressor response have been unclear. We observed a 45%
increase in CO with muscle metaboreflex activation during exercise with no significant
peripheral vasoconstriction. We determined the extent of peripheral vasoconstriction by
calculating the conductance of all vascular beds with the exception of the hindlimbs
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(NIVC) (13). Changes in hindlimb conductance must be excluded due to the mechanical
effects of the occlusion.
Previous studies have demonstrated a “switch” in the mechanisms of the muscle
metaboreflex from a flow-mediated rise in MAP to a vasoconstriction-mediated pressor
response when the reflex increase in CO is attenuated. For example, Sheriff et al. (140)
and Ichinose et al. (68) demonstrated substantial peripheral vasoconstriction when the
metaboreflex-induced increase in CO was either pharmacologically or mechanically
prevented.

In addition, Augustyniak et al. (14) demonstrated a shift from CO to

peripheral vasoconstriction when workload approached maximal levels and further
increases in CO were limited. Similar results have been observed in subjects with
congestive heart failure, a setting where substantial increases in CO are limited (12; 29;
59; 121). Thus whether or not increased CO or increased vasoconstriction is utilized as
a means to raise MAP with metaboreflex activation during dynamic exercise appears
dependent on the ability to increase CO.
Muscle metaboreflex activation during PEMI. CO versus vasoconstriction.
Previous studies have come to markedly different conclusions regarding the relative
roles of CO versus peripheral vasoconstriction in mediating the pressor response during
PEMI [(19; 30-32; 123; 132; 144) versus (16; 32; 123)]. One potential explanation is
that a CO response is often seen during imposed PEMI following more intense exercise,
whereas PEMI following relatively lower exercise intensities tends to demonstrate little
change in CO and the pressor response occurs via peripheral vasoconstriction. We
observed a maintained elevation in CO (~50% above the normal recovery level) during
PEMI with little or no change in NIVC. The time course of the recovery of NIVC during
PEMI and the normal recovery from exercise are virtually indistinguishable and not
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significantly different. It should be noted that NIVC contains not only conductance to
inactive areas, but a substantial amount of NIVC is skeletal muscle outside of the
hindlimbs (58), which also vasodilates in response to the exercise. Thus with exercise
NIVC increases and during recovery NIVC falls. To what extent this fall in NIVC during
recovery with or without PEMI is neurogenic versus passive vasoconstriction due to
reduced metabolic vasodilation in skeletal muscle is not known. Previously, Sheriff et
al. (141) has shown that after ganglionic blockade, skeletal muscle vasodilation during
exercise markedly exceeds normal levels.

Regardless of whether or not tonic

sympathetic activity controls the speed of recovery of NIVC, it is clear that the pattern of
change in NIVC was not different between the normal recovery and during PEMI.
Role of HR and SV in mediating metaboreflex-induced increases in CO during
exercise versus PEMI. Previous studies in dogs and humans have concluded that HR
and CO increase markedly when the muscle metaboreflex is activated during exercise
(12-14; 27; 29-31; 38; 59; 68; 116; 163); however, during PEMI the effects on HR are
more variable.

In general, PEMI elicited from the arm following moderate exercise

evokes little sustained tachycardia and any CO response occurs via increased SV (5;
45; 123). In contrast, if PEMI follows leg exercise, HR remains above normal recovery
values, and therefore the relative tachycardia contributes to an elevated CO (5; 45;
123).

The observations in humans following leg exercise are similar to those we

observed in the present study using canines. Collectively, these studies indicate that
either the HR response during PEMI depends on which limb is used or that these
differential responses are due to differences in muscle mass.
Previous studies from our laboratory and others have concluded that during
PEMI there are sustained increases in sympathetic tone to the heart; however, there are
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concurrent increases in parasympathetic activity as well (69; 111; 114). This combined
activation of both arms of the autonomic nervous system causes bradycardia but
sustained increased ventricular contractility (Figure 2.3). The differences in the HR
responses between PEMI and metaboreflex activation during dynamic exercise may
reflect that during PEMI one is observing responses during the recovery from exercise
rather than during exercise per se. Muscle metaboreflex-induced tachycardia occurs
primarily via increased sympathetic activity to the heart (44; 114). With the cessation of
exercise, parasympathetic activity rises abruptly, which masks the chronotropic effects
of sustained sympathetic tone (note that the inotropic effect is well sustained during
PEMI; (Figure 2.3). The extent to which sympathetic nerve activity remains elevated
during PEMI may be dependent on the intensity and type of exercise performed (e.g.,
isometric vs. isotonic).

For example, in canines, the muscle metaboreflex is not

tonically active during mild, free-flow treadmill exercise but becomes tonically active as
workload increases and/or ventricular function declines (14; 60; 163).

In addition,

Fisher et al. (44) demonstrated in humans performing static handgrip exercise that
“robust” muscle metaboreflex activation (achieved during high-intensity exercise) was
required to sustain sympathetic nerve activity during PEMI to a degree such that the
prevailing parasympathetic effects on HR were counteracted. However, Amann et al.
(7) recently concluded that skeletal muscle afferents contribute to the cardiorespiratory
responses during relatively mild exercise in humans.
The increases in CO with metaboreflex activation likely require increased
contractility as well as central blood volume mobilization to raise or maintain SV with the
elevated afterload and shortened ventricular filling time.

Previous studies from our

laboratory showed that the muscle metaboreflex can elicit marked increases in central
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blood volume mobilization (140) as well as ventricular contractility [as evidenced by
increased left ventricular maximal elastance, preload recruitable stroke work, as well as
dP/dtmax (27; 116; 138)]. Moreover, Little et al. (92; 93) have shown that increases in
left ventricular end-diastolic volume per se can lead to increases in dP/dtmax. Thus it is
possible that a portion of the rise in contractility with metaboreflex activation may be
directly attributable to enhanced central blood volume mobilization.
In the present study, the increase in contractility was sustained during PEMI
(Figure 2.3).

Shoemaker et al. (144) showed a substantial muscle metaboreflex-

induced increase in SV during ischemic exercise, and Crisafulli et al. (30) also reported
an increase in SV and ventricular contractility with muscle metaboreflex activation
during PEMI. These reflex increases in SV were suggested by these authors to be the
principal mechanisms behind the increase in CO in these two distinct settings as HR
was not affected.

We did not observe a significant increase in SV with muscle

metaboreflex activation during exercise or PEMI in our studies, and it is possible that
these different results are species dependent.

For example, there are reports that

canines have a limited end-diastolic reserve compared to humans (17). In contrast,
other studies have shown that canines possess significant preload reserve (90; 96).
Nonetheless, a maintenance or increase in SV during a hemodynamic period in which
ventricular filling time is markedly reduced can likely only be achieved if there is an
increase in the contractile state and/or an increase in preload.
Perspectives and Significance.

Activation of the muscle metaboreflex both

during submaximal exercise and during the recovery from exercise elicits substantial
increases in ventricular function. The major mechanism of the muscle metaboreflexmediated

pressor

response

is

increased

CO

with

little,

if

any,

peripheral
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vasoconstriction in both settings. Inasmuch as when workload rises, an increasingly
smaller fraction of CO is directed to non-active vascular beds (e.g., brain, kidneys and
splanchnic organs), even complete vasoconstriction of these beds would cause only a
limited increase in arterial pressure (113). In contrast, a metaboreflex-mediated rise in
CO generates substantial increases in arterial pressure. Thus, in these settings, the
muscle metaboreflex is a flow-raising, pressure-raising reflex. The rise in total systemic
blood flow increases systemic perfusion pressure which likely acts to partially restore
blood flow to ischemic muscle (120).
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CHAPTER 3
Mechanisms Mediating the Muscle Metaboreflex Pressor Response during PostExercise Muscle Ischemia are altered in Hypertension
Abstract
During dynamic exercise, muscle metaboreflex activation (MMA; induced via
partial hindlimb ischemia) markedly increases mean arterial pressure (MAP) and MAP is
sustained when the ischemia is maintained following the cessation of exercise (postexercise muscle ischemia – PEMI). We previously reported that the sustained pressor
response during PEMI in normal individuals is driven by a sustained increase in cardiac
output (CO) with no peripheral vasoconstriction. However, we have recently shown that
the rise in CO with MMA is significantly blunted in hypertension (HTN).

The

mechanism(s) sustaining the pressor response during PEMI in HTN are virtually
unknown.

In six chronically instrumented canines, hemodynamic responses were

observed during rest, mild exercise (3.2 km/h), MMA and PEMI in the same animals
before and after the induction of HTN (Goldblatt 2K1C). In control, MAP, CO and HR
increased with MMA (+52 ± 6 mmHg, +2.1 ± 0.3 l/min and +37 ± 7 bpm). After the
induction of HTN, MAP at rest increased from 97 ± 3 to 130 ± 4 mmHg, and the
metaboreflex responses were markedly attenuated (+32 ± 5 mmHg, +0.6 ± 0.2 l/min
and +11 ± 3 bpm). During PEMI in HTN, HR and CO were not sustained and MAP fell
to normal recovery levels. We conclude that the attenuated metaboreflex-induced HR,
CO and MAP responses are not sustained during PEMI in HTN.
Introduction
The muscle metaboreflex is a very powerful blood pressure-raising reflex (4; 11;
24; 46; 116; 132; 136; 163). Metabolically-sensitive afferents of this reflex (group III/IV)
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are stimulated by metabolites (e.g., protons, lactate, potassium and diprotonated
phosphate) which accumulate within underperfused active skeletal muscle (21; 34; 79;
86; 95; 128; 130; 145-147; 157). Activation of the muscle metaboreflex results in a
reflex increase in sympathetic outflow from the brainstem (20; 71; 75; 79; 98-100; 158).
During submaximal dynamic exercise, metaboreflex activation markedly increases heart
rate (HR), cardiac output (CO) and ventricular contractility (dP/dtmax) with no net effect
on the peripheral vasculature (14; 30; 31; 59; 68; 144; 150; 163).

Therefore, the

substantial metaboreflex-mediated pressor response observed during mild dynamic
exercise is virtually solely the result of the increase in CO.
In contrast, when metaboreflex activation is maintained following the cessation of
submaximal dynamic exercise (post-exercise muscle ischemia - PEMI) in normal
subjects, the pressor response is sustained despite several investigators reporting that
HR falls towards resting levels (4; 5; 45; 123; 133; 134; 158; 159; 161). The fall of HR
during PEMI led many investigators to question the role of CO in mediating the
sustained pressor response during PEMI (45; 133; 134; 159).

We recently

demonstrated that the sustained pressor response during PEMI following submaximal
dynamic exercise is principally driven by elevated CO, not peripheral vasoconstriction
(150). The sustained elevation in CO during PEMI is driven by enhanced chronotropy
(5; 31; 43; 67; 114; 138; 163) coupled with a sustained or slightly elevated stoke volume
(SV) (27; 31; 116; 138; 144; 150) which is supported by enhanced inotropy (dP/dtmax)
(27; 30; 68; 116; 138; 150), lusitropy (dP/dtmin) (68; 150) and central blood volume
mobilization (140). Therefore, the mechanisms mediating muscle metaboreflex-induced
increases in MAP are similar regardless of whether the reflex is activated during
dynamic exercise or if it is sustained during the recovery from exercise (150).
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Very recently, we reported attenuated metaboreflex-induced chronotropic,
inotropic and lusitropic responses in hypertension (HTN) during submaximal dynamic
exercise (136). Several studies from our group (12; 14; 59; 68; 121; 140) and others
(29) have demonstrated a “switch” from a flow-mediated to a vasoconstriction-mediated
pressor response during exercise when the reflex increase in CO is artificially
attenuated (68; 140) or when there is a physiological inability to increase CO, such as
during severe exercise (14) or in heart failure (12; 29; 59; 121). Thus, it appears that
whether or not increases in CO or peripheral vasoconstriction is utilized as a means to
raise MAP with metaboreflex activation during dynamic exercise is dependent on the
ability to increase CO.
The mechanisms sustaining the pressor response during PEMI in HTN are
virtually unknown.

Inasmuch as metaboreflex-induced increases in HR, CO and

dP/dtmax are markedly attenuated in HTN, we tested the hypothesis that the sustained
pressor response during PEMI would be principally supported by increased peripheral
vasoconstriction, not CO.
Methods
Experimental subjects. Six adult female mongrel canines were selected for the
study. All animals were healthy, ~20-25 kg body weight, well adapted to the laboratory
environment and willing to run on a motor-driven treadmill. During experimentation, all
animals exercised voluntarily and no negative reinforcement techniques were utilized.
The protocols developed and employed in the present study were reviewed and
approved by the Institutional Animal Care and Use Committee of Wayne State
University and complied with the National Institutes of Health Guide to the Care and
Use of Laboratory Animals.
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Surgical procedures. The animals were prepared as described previously (136).
Briefly, in the first sterile surgical procedure (left thoracotomy), an ultrasonic
perivascular flow probe was positioned around the ascending aorta to measure CO and
the catheter of an implantable telemetry blood pressure transmitter was inserted and
secured into the left ventricle to measure left ventricular pressure (LVP). In the second
surgical procedure, ultrasonic perivascular flow probes were placed around the terminal
aorta and left renal artery for measuring hindlimb blood flow (HLBF) and renal blood
flow (RBF), respectively. Two perivascular hydraulic occluders were positioned around
the terminal aorta (distal to the flow probe) to provide the means to incrementally reduce
HLBF in order to engage the muscle metaboreflex. One perivascular hydraulic occluder
was positioned around the left renal artery (distal to the flow probe) in order to reduce
RBF to induce HTN (2K1C Goldblatt model). Lastly, a catheter was secured into the
terminal aorta (cranial to the flow probe and occluders) to measure arterial pressure.
Following both surgical procedures, buprenorphine (0.05 mg/kg IV) and
acepromazine (0.5 mg/kg IM) were administered for analgesia and sedation,
respectively.

The animals were treated with cefazolin (30 mg/kg IV) pre- and

postoperatively and with cephalexin (30mg/kg PO, twice daily) prophylactically for the
term of the experimental protocol. The animals were allowed a minimum of ten days for
recovery between surgical procedures and a minimum of seven days before running
control experiments.
Data acquisition.

After complete postoperative recovery, each animal was

brought into the laboratory and allowed to roam freely and acclimate for approximately
15-20 minutes.

The animal was then directed onto the treadmill where the

instrumentation was connected to the data acquisition system. CO, CBF, HLBF and
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RBF flow probe cables were connected to transit-time perivascular flow meters (TS420,
Transonic Systems). The LVP telemetry signal was collected by a receiver connected
to a calibrated analog adapter and a barometric pressure reference device (RMC-1,
R11CPA, APR-1, respectively; DSI). The arterial catheter was connected to a pressure
transducer (Transpac IV, ICU Medical). All aforementioned hemodynamic variables, in
addition to MAP (calculated) and HR (triggered by the CO signal), were monitored as
beat-by-beat averages and real-time waveforms by a data acquisition system
(LabScribe, iWorx) and recorded for subsequent off-line analysis.
Induction of hypertension. After completion of control experiments, HTN was
induced via a Goldblatt 2K1C model (47; 48). Blood flow to the left kidney was reduced
to a target level of ~30% of baseline via partial inflation of the renal vascular occluder.
HTN gradually developed over the next several weeks. We defined HTN as systolic
pressure ≥140 mmHg and diastolic pressure ≥90 mmHg.

The experiments were

repeated after 31.5 ± 3.4 days of sustained HTN.
Experimental design. Each animal performed two experimental protocols before
(normal) and after induction of HTN, and therefore each animal served as its own
control. On each day, the experimental protocol sequence was randomized to avoid
any order effect. All experiments began with the animal standing unrestrained on the
treadmill until all hemodynamic resting data were observed to be stable (~5-10 min).
The treadmill was turned on and the speed was gradually increased to 3.2 km/h at 0%
grade (mild exercise for a canine). Steady-state exercise was generally reached within
3-5 minutes. The following is the design of the two experimental protocols:
1) Free-flow Exercise and Post-exercise Recovery: Following the 3.2 km/h steadystate, the treadmill was abruptly stopped and post-exercise recovery (without
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ischemia – i.e., free-flow) hemodynamic data were collected for 60 seconds while
the animal was standing still.
2) Muscle Metaboreflex Activation and Post-exercise Muscle Ischemia: Following the
3.2 km/h steady-state, the metaboreflex was engaged during the exercise via partial
reductions in HLBF and steady-state data were collected for 60 seconds.

The

treadmill was then abruptly stopped and the occlusion was sustained for an
additional 60 seconds while the animal was standing still.
Data analysis. CO, HLBF, LVP, HR and MAP data were continuously recorded
during each experiment. Other hemodynamic parameters were calculated off-line (e.g.,
SV, non-ischemic vascular conductance (NIVC), total peripheral resistance (TPR),
dP/dtmax and dP/dtmin). Due to technical difficulties, we were only able to obtain dP/dtmax
and dP/dtmin data for five animals. One minute averages of steady-state data were
calculated at rest, during exercise and during metaboreflex activation.

5 second

averages were computed for the 60 seconds of post-exercise recovery and PEMI.
Responses for these two settings were taken as the last averaged 10 seconds. Mean
values were averaged across all animals to obtain mean values for the entire population
of the study.
Statistical analysis. Averaged responses for each animal were analyzed via twoway repeated measures ANOVA to compare hemodynamic data for time and/or
condition effects. In the event of a significant time-condition interaction, a C-matrix test
for simple effects was performed. Data are reported as means ± SE and statistical
significance was ascribed as p<0.05.
Results
Following induction of HTN, MAP was significantly elevated at rest which was
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due to an increase in TPR (Table 3.1).
Table 3.1. MAP, CO and TPR (mmHg, l/min and mmHg/l/min ± SE, respectively) during
rest, exercise (EX), muscle metaboreflex activation (MMA) and the last 10 s of postexercise muscle ischemia (PEMI) before (normal) and after induction of hypertension.
Hypertension

Normal

MAP
REST
EX
MMA
PEMI

96.9 ± 2.9
101.8 ± 3.6
153.5 ± 4.9
151.5 ± 5.0

CO
3.45 ± 0.20
4.91 ± 0.32
7.03 ± 0.60
5.19 ± 0.49

TPR

MAP

28.7 ± 2.2
21.4 ± 2.0
22.6 ± 2.0
28.5 ± 2.1

129.5 ± 3.7*
124.8 ± 4.4*
156.7 ± 6.5
142.6 ± 6.8

CO
3.56 ± 0.26
4.92 ± 0.25
5.49 ± 0.36*
4.08 ± 0.38*

TPR
37.4 ± 3.1*
25.8 ± 1.8*
29.0 ± 1.8*
36.0 ± 2.6*

* - p<0.05 normal vs. hypertension

Figure 3.1 shows responses in MAP, CO, HR, SV and HLBF from one animal
during rest, mild dynamic exercise, muscle metaboreflex activation and PEMI before
Figure 3.1. Time-course of
mean
arterial
pressure
(MAP), cardiac output (CO),
heart rate (HR), stroke
volume (SV) and hindlimb
blood flow (HLBF) during
rest, mild exercise, muscle
metaboreflex
activation
(MMA) AND PEMI before
(normal) (dotted black lines)
and
after
induction
of
hypertension (solid black
lines) in one animal. Data
represented are the final 60 s
of steady-state data during
rest, exercise and MMA. 60 s
of PEMI immediately followed
the MMA steady-state.
(normal) and after induction of HTN. Resting MAP was markedly elevated following
induction of HTN while CO, HR, SV and HLBF were similar to the levels observed prior

35
to induction of HTN. From rest to exercise, CO, HR and HLBF markedly increased
while MAP and SV remained similar to the values observed at rest.

These

cardiovascular responses were similar following induction of HTN. MAP, CO, HR and
SV significantly increased with muscle metaboreflex activation, however these
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reduced to the same level to induce muscle metaboreflex activation and was similarly
maintained during PEMI before and after induction of HTN.

Metaboreflex-induced

increases in MAP, HR, CO and NIVC were markedly attenuated following induction of
HTN. During PEMI, HR, CO and NIVC were significantly lower than normal during the
entire 60 seconds of PEMI following induction of HTN, while MAP was not any different.
Figure 3.3 shows mean hemodynamic responses in MAP, NIVC, CO, HR, SV,
dP/dtmax and dP/dtmin during rest, mild exercise and the final averaged 10 seconds of
post-exercise recovery before and after induction of HTN. Resting MAP and dP/dtmax
were significantly elevated, NIVC significantly reduced and CO, HR, SV and dP/dtmin

Figure 3.3. Mean hemodynamic responses in MAP, NIVC, CO, HR, SV, dP/dtmax and
dP/dtmin during rest, mild exercise (EX) and post-exercise recovery (POST-EX) before
(open bars) and after induction of HTN (filled bars). * - p<0.05 between normal and HTN;
†
- p <0.05 from previous setting
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were similar to normal following induction of HTN.

NIVC, CO, HR and dP/dtmax

significantly increased from rest to mild exercise while MAP, SV and dP/dtmin were
unchanged. Following induction of HTN, NIVC were reduced during exercise, CO and
HR significantly increased as in normal, while MAP, SV and dP/dtmax and dP/dtmin were
similar to rest. During the final averaged 10 seconds of post-exercise recovery, MAP,
SV and dP/dtmin remained unchanged while NIVC, CO, HR and dP/dtmax fell to levels not
significantly different from those observed at rest (p>0.05). Following induction of HTN,
MAP, SV and dP/dtmin remained unchanged while CO and HR fell to rest as in normal.
NIVC was significantly reduced and dP/dtmax significantly elevated with respect to
normal and both parameters fell to rest (p>0.05; rest vs. post-exercise recovery).
Figure 3.4 shows mean hemodynamic responses in MAP, NIVC, CO, HR, SV,
dP/dtmax and dP/dtmin during rest, mild exercise, muscle metaboreflex activation and the
final averaged 10 seconds of PEMI before and after induction of HTN.

All

hemodynamic responses at rest and during mild exercise before and after induction of
HTN were similar as shown in Figure 3.3. All cardiovascular parameters significantly
increased with muscle metaboreflex activation, however following induction of HTN
metaboreflex-induced increase in these parameters were markedly attenuated. During
the final averaged 10 seconds of PEMI, all parameters fell significantly below
metaboreflex activation levels and, with the exception of NIVC, all remained significantly
elevated above post-exercise recovery levels. Following induction of HTN, SV, dP/dtmax
and dP/dtmin remained at metaboreflex activation levels while MAP, NIVC, CO and HR
fell to levels not significantly different from those observed during post-exercise
recovery without PEMI.
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Figure 3.4. Mean hemodynamic responses in MAP, NIVC, CO, HR, SV, dP/dtmax and
dP/dtmin during rest, mild exercise (EX), MMA and PEMI before (open bars) and after
induction of HTN (filled bars). * - p<0.05 between normal and HTN; † - p <0.05 from
previous setting; # - p<0.05 between POST-EX and PEMI.

Discussion
Our major new findings are that the attenuated muscle metaboreflex-induced
pressor response in HTN is not sustained during PEMI and the mechanisms sustaining
the pressor response during PEMI in normal subjects are altered in HTN.
Muscle metaboreflex activation during exercise in normal subjects elicits a
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substantial pressor response which is sustained during PEMI (4; 16; 19; 30-32; 45; 46;
102; 123; 132; 144; 157; 161). We recently demonstrated that this sustained pressor
response during PEMI is supported by a sustained increase in CO and not peripheral
vasoconstriction (150).

The sustained CO during PEMI was driven by enhanced

chronotropy coupled with a sustained SV which was supported by enhanced inotropy
and lusitropy.

We further concluded that the mechanisms mediating metaboreflex-

induced pressor responses are similar both when the reflex is activated during dynamic
exercise and when the reflex is sustained during the recovery from exercise (PEMI).
Several studies have demonstrated a

“switch”

from

a

flow-mediated

to a

vasoconstriction-mediated pressor response during exercise when the reflex increase in
CO is attenuated (14; 29; 59; 68; 140). In the present study we observed substantially
attenuated metaboreflex-induced CO and MAP responses in HTN as recently shown by
Sala-Mercado et al. (136).

However, the pressor response during PEMI was not

sustained via enhanced peripheral vasoconstriction. During PEMI, CO, HR, dP/dtmax
and dP/dtmin fell to normal recovery levels and, despite a downward baseline shift in
NIVC during all settings, the recovery pattern of NIVC was similar to control indicating
no increase in peripheral vasoconstriction. Therefore, the attenuated pressor response
was not sustained during PEMI in HTN.
Few studies have investigated muscle metaboreflex function during PEMI in HTN
and the findings are equivocal.

Farquhar and colleagues recently demonstrated in

elderly hypertensive humans that the pressor response to static handgrip exercise (3040% MVC) is exaggerated in HTN and sustained during PEMI (35; 52). However, in a
previous study from this group with similar subjects (139), the pressor response to
rhythmic handgrip exercise (60% MVC) was not exaggerated in HTN, yet MAP was
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sustained during PEMI. In contrast, Rondon et al. (126) did not find an exaggerated
pressor response to static handgrip exercise (30% MVC) in humans with untreated HTN
and blood pressure fell to baseline during PEMI. While the lack of a sustained pressor
response during PEMI in the hypertensive groups is in agreement with the present
study, the absence of a sustained pressor response during PEMI in the normotensive
group is perplexing. The lack of congruency of the present and aforementioned studies
may be due to several confounding factors including: differences in species, age, type
and intensity of exercise performed and experimental methodology.

We discussed

several of these issues in a previous study (150).
Studies from Farquhar and colleagues have reported sustained elevations in
muscle sympathetic nerve activity (MSNA) during PEMI in HTN indicating enhanced
peripheral vasoconstriction (35; 52).

However, as CO was not measured in these

studies, to what extent CO contributed to the maintenance of MAP during PEMI is
unknown. The conflicting results of the present study and those from Farquhar and
colleagues is potentially due to differences in exercise intensity and the muscle group in
which the reflex was evoked. For example, CO responses are often seen during PEMI
following more intense exercise, whereas with PEMI following lower intensity exercise
the pressor response occurs primarily via peripheral vasoconstriction (19; 30; 32; 144).
In our model we robustly activated the metaboreflex, whereas Farquhar and colleagues
elicited the reflex only during 30-40% MVC. Moreover, as opposed to evoking the reflex
from one arm, we engage the reflex from both hindlimb muscles during full body
dynamic exercise. In general, with PEMI following leg exercise, HR and CO remain
elevated, while with PEMI following moderate arm exercise there is little HR or CO
response (5; 45; 123). Therefore, it is possible that the experimental model of Farquhar
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and colleagues is one that is driven by peripheral vasoconstriction and not CO. Indeed
previous studies both support (19; 30-32; 123; 132; 144; 150) and refute (16; 32; 123)
any role for CO in mediating the pressor response during PEMI. As such, we would not
expect the pressor response to fall during PEMI in HTN as in our model.
Contrary to our hypothesis, we did not observe a vasoconstriction-mediated
pressor response during PEMI in HTN.

Following induction of HTN, there was a

marked downward baseline shift in NIVC during all settings indicating enhanced
peripheral vasoconstriction, however the recovery pattern of NIVC during PEMI was
similar to control indicating no increase in peripheral vasoconstriction. In the present
study, and a few previous studies (14; 27; 28; 83), we observed a small, but significant
increase in NIVC with metaboreflex activation. We have concluded from preliminary
data that this significant increase in peripheral vascular conductance is due to a
metaboreflex-induced release of epinephrine from the adrenal glands mediating a β2mediated vasodilation (80).

The rise in NIVC with metaboreflex activation after

induction of HTN was blunted. Whether this is due to reduced epinephrine release,
fewer beta receptors or enhanced sympathetic α1-mediated vasoconstriction opposing
the β2-mediated vasodilation is unknown.
In summary, we previously demonstrated in normal subjects that CO sustains the
pressor response during PEMI. Following induction of HTN, metaboreflex-induced CO
and HR responses were markedly attenuated and the mechanisms sustaining the
pressor response during PEMI were altered as CO and HR fell to normal recovery
levels. Moreover, the recovery pattern of NIVC during PEMI was similar to control
indicating no increase in peripheral vasoconstriction. Therefore, the attenuated pressor
response was not sustained during PEMI in HTN.
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CHAPTER 4
Exaggerated Coronary Vasoconstriction Limits Muscle Metaboreflex-Induced
Increases in Ventricular Performance in Hypertension
Abstract
Increases in myocardial oxygen consumption mainly occur via increases in
coronary blood flow (CBF) inasmuch as cardiac oxygen extraction is high even at rest.
However, during exercise, sympathetically-mediated constrictor tone can limit increases
in CBF. Increased sympathetic nerve activity (SNA) during exercise may stem from
muscle metaboreflex activation (MMA). SNA is often elevated even at rest in subjects
with hypertension (HTN).

We tested whether HTN causes exaggerated coronary

vasoconstriction during mild treadmill exercise with MMA (imposed via reducing
hindlimb blood flow by ~60%) which thereby limits increases in CBF and ventricular
performance. Experiments were repeated after α1-adrenergic blockade (prazosin; 75
µg/kg) and in the same animals following induction of HTN (Goldblatt 2K1C model).
HTN increased mean arterial pressure from 97.1 ± 2.6 to 132.1 ± 5.6 mmHg at rest and
MMA-induced increases in CBF, left ventricular dP/dtmax and cardiac output were
markedly reduced to only 32 ± 13%, 26 ± 11% and 28 ± 12% of the changes observed
in control.

In HTN, α1-adrenergic blockade restored the coronary vasodilation and

increases in ventricular function to the levels observed when normotensive.

We

conclude that in HTN, exaggerated MMA-induced increases in SNA functionally
vasoconstrict the coronary vasculature impairing increases in CBF which limits oxygen
delivery and ventricular performance.
Introduction
When oxygen demand of working skeletal muscle exceeds oxygen supply the
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muscle releases metabolites (e.g., hydrogen ion (21; 157), potassium ion (95),
diprotonated phosphate (21; 146), lactate (34; 86; 128; 143; 147) and ATP (62; 91;
153)) which stimulate metabolically-sensitive group III/IV afferents (3; 7; 24; 86; 102;
128). This reflexively increases sympathetic outflow from the brainstem – termed the
muscle metaboreflex (20). When engaged during submaximal dynamic exercise, the
metaboreflex increases heart rate (HR) and ventricular contractility resulting in large
increases in cardiac output (CO) and mean arterial pressure (MAP) (4; 11; 31; 38; 94;
116; 132; 150; 163). The rise in CO is driven by marked increases in HR (5; 31; 43; 67;
114; 138; 163) coupled with a sustained or slight increase in stroke volume (SV) (27;
31; 116; 138; 144; 150) which is supported via enhanced ventricular contractility
(dP/dtmax) (27; 30; 68; 116; 138), lusitropy (dP/dtmin) (68; 150) and central blood volume
mobilization (CBVM) (140). This increase in CO is the primary mechanism mediating
the rise in arterial blood pressure as little if any net peripheral vasoconstriction is
observed (14; 30; 59; 68; 144; 150; 163). Therefore, the muscle metaboreflex has been
described as a flow-sensitive, flow-raising reflex (120) that works to improve oxygen
supply to the ischemic working muscle (117).
During exercise, the increased cardiac oxygen demand is met primarily via
increases in CBF inasmuch as oxygen extraction is already ~80% even at rest (37; 40;
156).

The rise in CBF is achieved via coronary metabolic and feed-forward, β2-

adrenergic vasodilation (37; 40; 156) which is restrained by the vasoconstrictor actions
of the rise in cardiac SNA (57). Muscle metaboreflex activation increases CBF solely
via the large increase in MAP; despite large increases in cardiac work (greater CO
pumped against a higher afterload), no coronary vasodilation occurs due to enhanced
α1-adrenergic-mediated coronary vasoconstriction (10; 27; 119).

Blockade of the
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constrictor tone increases CBF during muscle metaboreflex activation resulting in
improved ventricular performance and CO (27; 28; 119).
Resting SNA is heightened in hypertension (HTN) (51; 54; 72; 97; 101; 105;
155). Moreover, an enhanced sympathetically-mediated coronary constrictor tone and
restrained coronary metabolic vasodilation during dynamic exercise has been
demonstrated in HTN (55). Recent studies support (23; 35; 52; 106; 107; 139) and
refute (126) accentuated muscle metaboreflex function in HTN.

Very recently, we

reported attenuated metaboreflex-induced chronotropic and inotropic responses in HTN
(136). We hypothesized that enhanced coronary vasoconstriction contributes to the
impaired ability to increase ventricular performance during muscle metaboreflex
activation in HTN.
Methods
Experimental subjects. Six mongrel canines were designated for the study. All
animals were healthy, adult, female, ~20-25 kg in body weight, acclimatized to the
laboratory surroundings and willing to run on a motor-driven treadmill.

During

experimentation, all animals exercised voluntarily and no negative reinforcement
techniques were utilized. The protocols developed and employed in the present study
were approved by the Institutional Animal Care and Use Committee (IACUC) of Wayne
State University and complied with the National Institutes of Health Guide to the Care
and Use of Laboratory Animals.
Surgical procedures. Each animal was completely instrumented with chronic,
indwelling cardiovascular devices following two sterile surgical procedures: left
thoracotomy followed by a left flank retroperitoneal surgery. The animals recovered a
minimum of ten days prior to the second surgery and a minimum of seven days prior to
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the first experiment. During preoperative care, the animals were initially sedated with
acepromazine (0.4-0.5 mg/kg IM).

Following adequate sedation, the animals were

anesthetized with a combined treatment of ketamine and diazepam (5.0 and 0.22 mg/kg
IV, respectively).

Anesthesia was maintained with isoflurane gas (1-3%) following

endotracheal intubation. In addition, the animals received preoperative administration
of cefazolin (antibiotic, 30 mg/kg IV), carprofen (analgesic, 2.0 mg/kg IV), buprenorphine
(analgesic, 0.01 mg/kg IM) and fentanyl (analgesic, 125–175 µg/h (72h) TDD). Prior to
the left thoracotomy, animals received selective intercostal nerve blockade with
bupivacaine HCL (2.0 mg/kg). Following each surgical procedure, animals received
cefazolin (30 mg/kg IV) and prophylactic cephalexin (antibiotic, 30 mg/kg (BID) PO)
therapy for the term of the experimental protocol. During the 12h postoperative period,
animals were closely monitored and received buprenorphine and acepromazine (0.05
and 0.5 mg/kg IV, respectively) as needed to control any potential discomfort. For the
following 10 days, animals received carprofen (4 mg/kg (OPD) PO).
In the first surgical procedure, the thoracic cavity was opened via a left
thoracotomy (4th intercostal space) approach. The pericardium was cut and reflected to
expose the heart. An ultrasonic perivascular flow probe (20PAU, Transonic Systems)
was positioned around the ascending aorta to measure CO.

Approximately 10 cm

caudal to the thoracotomy incision, an implantable telemetry blood pressure transmitter
(TA11 PA-D70, Data Sciences International) was tethered subcutaneously.

The

catheter of the transmitter was tunneled into the thoracic cavity through the 7th
intercostal space and the tip was inserted and secured inside the left ventricle for
measuring left ventricular pressure (LVP).

Lastly, the left atrial appendage was

reflected and the circumflex branch of the left coronary artery was exposed.

An
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ultrasonic perivascular flow probe (3PSB, Transonic Systems) was positioned around
the circumflex artery to measure coronary blood flow (CBF).

The pericardium was

loosely re-approximated, the cables were tunneled subcutaneously and exteriorized
between the scapulae and the chest was closed in layers.
In the second surgical procedure, an incision was made in the left flank cranial to
the iliac crest. The abdominal aorta was exposed and an ultrasonic perivascular flow
probe (10PAA, Transonic Systems) was positioned around it for measuring hindlimb
blood flow (HLBF). All side branches of the terminal aorta, between the common iliacs
and the flow probe, were ligated and severed. In addition, two perivascular hydraulic
occluders (8-10 mm, DocXS Biomedical Products) were positioned around the terminal
aorta (distal to the flow probe) to provide the means to incrementally reduce HLBF. A
19-gauge polyvinyl catheter (Tygon, S54-HL, Norton) was advanced through a ligated
lumbar artery and secured into the terminal aorta cranial to the probe and occluders to
measure arterial pressure. Lastly, the left renal artery was exposed and an ultrasonic
perivascular flow probe (4PSB, Transonic Systems) was positioned around the vessel
to measure renal blood flow (RBF). A perivascular hydraulic occluder (4-6 mm, DocXS
Biomedical Products) was positioned around the renal artery (distal to the flow probe) to
provide the means to reduce RBF.

The cables and vascular occluder tubing were

tunneled subcutaneously and exteriorized between the scapulae and the abdomen was
closed in layers.
Data acquisition.

After complete postoperative recovery, each animal was

brought into the laboratory and allowed to roam freely and acclimate for approximately
15-20 minutes. Following this period, the animal was directed onto the treadmill where
its instrument cables and tubing were unpacked and prepared for data collection. The
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CO, RBF, CBF and HLBF flow probe cables were connected to transit-time perivascular
flow meters (TS420, Transonic Systems). The LVP transmitter was turned on and the
signal was collected via telemetry (Data Sciences International). The arterial catheter
was aspirated, flushed and connected to a pressure transducer (Transpac IV, ICU
Medical). All aforementioned hemodynamic variables, in addition to MAP (calculated)
and HR (triggered by the CO signal), were monitored as beat-by-beat averages and
real-time waveforms by a data acquisition system (LabScribe, iWorx) and recorded for
subsequent off-line analysis.
Induction of hypertension. HTN was induced via a modified Goldblatt (2K1C)
model (48). After competition of control experiments, blood flow to the left kidney was
reduced to a target level of ~30% of baseline via partial inflation of the renal vascular
occluder. The level of RBF was checked at least 2x/day and the vascular occluder
adjusted until flow was stable. HTN gradually developed over the next several weeks.
We defined HTN as a systolic pressure ≥ 140 mmHg and a diastolic pressure ≥ 90
mmHg. The experiments were repeated after 34.4 ± 1.6 days of sustained HTN. Thus,
the experiments were longitudinal in nature as each animal served as its own control.
Experimental procedures. Both control and experimental procedures began with
the animal standing unrestrained and still on the treadmill until all resting hemodynamic
data were observed to be stable (typically 5-10 min). The treadmill was turned on and
the speed was gradually increased to 3.2 km/h at 0% grade (mild exercise for a canine).
Steady-state was generally reached within 3-5 minutes. The muscle metaboreflex was
engaged via partial reductions in HLBF during mild, dynamic exercise.
Data analysis. CO, CBF, HLBF, RBF, LVP, HR and MAP data were continuously
recorded during each experimental procedure. Other hemodynamic parameters were
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calculated during off-line data analysis (e.g., stroke volume (SV), dP/dtmax, dP/dtmin, total
peripheral resistance (TPR), non-ischemic vascular conductance (NIVC), coronary
vascular conductance (CVC) and cardiac power (CP)). TPR, NIVC, CVC and CP were
calculated as (MAP/CO), [(CO-HLBF)/MAP], CBF/MAP and [(MAPxCO)/451] (42),
respectively. Due to technical difficulties, we were only able to obtain dP/dtmax data for
five animals. One minute averages of steady-state data were calculated at rest, during
exercise and during metaboreflex activation. Mean values were averaged across all
animals to obtain the population mean of the study.
For slope analysis (Figure 4.5, left panel), all data points were fitted to two linear
regression lines (initial response and metaboreflex-induced response lines) and three
points were used to characterize the responses: free-flow exercise (mild exercise with
no reduction in HLBF), threshold (intersection of the two linear regression lines) and
max (maximal metaboreflex-induced response at lowest imposed level of HLBF). For
Figure 4.7, a straight line was ascribed (via least squares linear regression analysis) to
all data points (i.e., all graded reductions) between and including free-flow exercise and
max (from left to right, respectively) for each of the four conditions. In Figure 4.8, the
ratio of the changes in CVC and CP from free-flow exercise to max (i.e., ∆CVC:∆CP)
were calculated for each of the four conditions. For Figure 4.9, a straight line was
ascribed (via least squares linear regression analysis) to all data points: rest, free-flow
exercise and max (from left to right, respectively) for each of the four conditions.
Statistical analysis. Averaged responses for each animal were analyzed with
Systat software (Systat 11.0). A P < 0.05 was set to determine statistical significance.
A two-way repeated measures ANOVA was used to compare hemodynamic data for
time and/or conditional effects. In the event of a significant time-condition interaction, a
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C-matrix test for simple effects was performed. Data are reported as means ± SE.
Results
Resting MAP and TPR were significantly elevated while CO was unaffected
following induction of HTN (Table 4.1).
Table 4.1. MAP, CO and TPR (mmHg, l/min and mmHg/l/min ± SE, respectively) at rest
in the same animals before (normal) and after induction of hypertension.
Hypertension

Normal
MAP

Rest

97.1 ± 2.6

CO

3.44 ± 0.18

TPR

28.7 ± 1.9

MAP

132.1 ± 5.6*

CO

3.56 ± 0.17

TPR

37.6 ± 2.4*

* - p<0.05 between normal and hypertension.

Average steady-state MAP, HR, SV, CO and NIVC (Figure 4.1) and CBF, CVC,
dP/dtmax and CP (Figure 4.2) values are shown during rest, mild exercise and muscle
metaboreflex activation in control and after α1-adrenergic blockade in normal animals
and in the same animals after induction of HTN.
Normal: control vs. α1-adrenergic blockade. In control, HR, CO, NIVC, CBF,
CVC, dP/dtmax and CP increased from rest to exercise, while MAP and SV remained
unchanged. Metaboreflex activation elicited increases in all cardiovascular parameters.
Following α1-adrenergic blockade, resting MAP and SV were lower, HR and CVC were
higher and CO, NIVC, CBF, dP/dtmax and CP were similar with respect to control. MAP,
HR, CO, NIVC, CBF, CVC, dP/dtmax and CP increased from rest to exercise, while SV
remained unchanged. Metaboreflex activation increased all cardiovascular parameters.
MAP and SV were lower, HR, CO, NIVC CBF, CVC and dP/dtmax were higher and CP
was similar with respect to control during metaboreflex activation.
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Figure 4.1. Average steady-state mean arterial pressure (MAP), heart rate (HR), stroke
volume (SV), cardiac output (CO) and non-ischemic vascular conductance (NIVC)
values during rest, mild exercise (EX) and muscle metaboreflex activation (MMA) in
control (filled bars) and after α1-adrenergic blockade (striped bars) in the same animals
before (normal) and after induction of hypertension. * - p<0.05 between control and α1adrenergic blockade; † - p<0.05 from previous setting.
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Hypertension: control vs. α1-adrenergic blockade. In HTN, HR, CO, NIVC, CBF,
CVC, dP/dtmax and CP increased from rest to exercise, while MAP and SV remained
unchanged. Metaboreflex activation elicited increases in MAP, HR, CO, NIVC, CBF,
dP/dtmax and CP, but did not affect SV and CVC. Following α1-adrenergic blockade,
resting MAP was lower, NIVC was higher and HR, SV, CO, CBF, CVC, dP/dtmax and CP
were similar with respect to control. HR, CO, NIVC, CBF, CVC and CP increased from
rest to exercise, while MAP, SV and dP/dtmax remained unchanged.

Metaboreflex
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activation increased MAP, HR, CO, NIVC, CBF, CVC, dP/dtmax and CP, but did not
affect SV. HR, CO, NIVC, CBF, CVC, dP/dtmax and CP were higher, SV lower and MAP
similar with respect to control during metaboreflex activation.
Hypertension

Normal
REST

EX

EX

MMA

REST

EX

EX

MMA

Figure 4.3. Average steady-state changes in MAP, HR, SV, CO and NIVC from rest to
mild exercise (EX) and mild exercise to muscle metaboreflex activation (MMA) in control
(filled bars) and after α1-adrenergic blockade (striped bars – prazosin (PZ)) in the same
animals before (normal) and after induction of hypertension. * - p<0.05 between control
and prazosin; # - p<0.05 between normal and hypertension.
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Average steady-state changes in MAP, HR, SV, CO and NIVC (Figure 4.3) and
CBF, CVC, dP/dtmax and CP (Figure 4.4) are shown from rest to mild exercise and mild
exercise to muscle metaboreflex activation in control and after α1-adrenergic blockade
in normal animals and in the same animals after induction of HTN.
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Figure 4.4. Average steady-state changes in CBF, CVC, dP/dtmax and CP from rest to
mild exercise (EX) and mild exercise to muscle metaboreflex activation (MMA) in control
(filled bars) and after α1-adrenergic blockade (striped bars – prazosin (PZ)) in the same
animals before (normal) and after induction of hypertension. * - p<0.05 between control
and prazosin; # - p<0.05 between normal and hypertension.
Normal vs. hypertension. Increases in NIVC from rest to exercise in normal
animals was significantly lower in the same animals following induction of HTN.
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Metaboreflex-induced increases in MAP, HR, SV, CO, NIVC, CBF, dP/dtmax and CP
were significantly attenuated following induction of HTN, while CVC was unaffected.
Following α1-adrenergic blockade, increases in MAP, HR, CO, NIVC, CBF, CVC,
dP/dtmax and CP from mild exercise to metaboreflex activation were not any different
from normal levels following α1-adrenergic blockade.
Figure 4.5 (left panel) shows stimulus-response relationships for MAP, CO, HR,
CBF, CVC and dP/dtmax during free-flow exercise, threshold and max, from right to left,
respectively.

Data were collected following graded reductions in HLBF during mild

exercise in control and after α1-adrenergic blockade in normal animals and in the same
animals after induction of HTN. The slopes of the metaboreflex-response lines are
indicative of the gain of the metaboreflex for each individual cardiovascular parameter.
Figure 4.5 (right panel) shows the changes in the slopes of the metaboreflex-induced
response lines for MAP, CO, HR, CBF, CVC and dP/dtmax in control and after
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Figure 4.5. (Left panel) Stimulus-response relationships for MAP, CO, HR, CBF,
CVC and dP/dtmax as a function of graded reductions in hindlimb blood flow (HLBF).
Data plotted are free-flow exercise, threshold and max (from right to left, respectively)
in control (solid lines/filled symbols) and after α1-adrenergic blockade (dashed
lines/open symbols) in the same animals before (normal) and after induction of
hypertension. (Right panel) Changes in the slopes of the metaboreflex-induced
response lines for MAP, CO, HR, CBF, CVC and dP/dtmax in control (filled bars) and
after α1-adrenergic blockade (striped bars – prazosin (PZ)) in the same animals
before (normal) and after induction of hypertension. * - p<0.05 between control and
prazosin; # - p <0.05 between normal and hypertension.
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α1-adrenergic blockade in normal animals and in the same animals after induction of
HTN.

Following α1-adrenergic blockade, the slopes of the metaboreflex-induced

response lines for CO, HR, CBF, CVC and dP/dtmax were significantly higher while MAP
was unchanged.

These slopes were significantly lower for all cardiovascular

parameters following induction of HTN, while α1-adrenergic blockade fully restored the
slopes (except CO; p=0.042) to normal levels following α1-adrenergic blockade.
The relationship between CVC and CP in one animal is shown in Figure 4.6. A
straight line was ascribed from rest to free-flow exercise. Linear regression analysis
was used fit a straight line through free-flow exercise and all subsequent reductions in
HLBF. The relationship from rest to max was exceedingly nonlinear. Therefore, resting
data were excluded and a straight line was ascribed to the remaining data points (i.e.,
free-flow exercise and all HLBF reductions) via linear regression analysis in order to
appropriately compare the slopes of the relationship before and after induction of HTN
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and with and without α1-adrenergic blockade (Figure 4.7).
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Figure 4.7 shows the relationship between CVC and CP in control and after α1adrenergic blockade in normal animals and in the same animals after induction of HTN
during rest, free-flow exercise and max (left to right, respectively). After induction of
HTN, the slope of the relationship (from free-flow exercise to max) was significantly
lower and the increase in CP was markedly attenuated.

Following α1-adrenergic

blockade, the slope of the relationship was significantly shifted upward and not any
different than during α1-adrenergic blockade prior to induction of HTN. Moreover, the
increase in CP was not any different following α1-adrenergic blockade before and after
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Figure 4.7. The relationships between CVC and CP during rest, free-flow exercise
and max (left to right, respectively) in control (solid lines/filled symbols) and after
α1-adrenergic blockade (dashed lines/open symbols) in the same animals before
(circles) and after induction of hypertension (triangles). * - p<0.05 max CP before
and after induction of hypertension.
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Figure 4.8 shows the ratio of the changes in CVC and CP from free-flow exercise
to max (i.e., ∆CVC:∆CP) in control and following α1-adrenergic blockade before and
after induction of HTN. Following α1-adrenergic blockade, ∆CVC:∆CP was significantly
greater than in control.
reduced.

Following induction of HTN, ∆CVC:∆CP was significantly

Following α1-adrenergic blockade, ∆CVC:∆CP was not any different than

during α1-adrenergic blockade prior to induction of HTN.
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Figure 4.8. Ratio of changes in CVC and CP from free-flow exercise to max (i.e.,
∆CVC:∆CP) in control (filled bars) and following α1-adrenergic blockade (striped
bars) in the same animals before (normal) and after induction of hypertension. * p<0.05 between control and α1-adrenergic blockade; † - p <0.05 between normal
and hypertension.
Figure 4.9 shows the relationship between dP/dtmax and CBF in control and after
α1-adrenergic blockade in normal animals and in the same animals after induction of
HTN. The slope of the relationship between dP/dtmax and CBF was exceedingly linear
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with all data points considered. After induction of HTN, metaboreflex-induced increases
in both dP/dtmax and CBF were significantly attenuated. However, metaboreflex-induced
increases in both dP/dtmax and CBF were not any different following α1-adrenergic
blockade before and after induction of HTN.
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Figure 4.9. Relationship between dP/dtmax and CBF in control (filled symbols) and
after α1-adrenergic blockade (open symbols) in the same animals before (normal)
(circles) and after induction of hypertension (triangles).
Discussion
Our major new findings are that after induction of HTN, increases in CBF during
metaboreflex activation are attenuated and the ability to increase ventricular contractility
is reduced. Blockade of α1-adrenergic receptors restored the increases in CBF and
ventricular function to normal levels indicating that the primary mechanism mediating
the impaired metaboreflex-induced increases in ventricular function in HTN is coronary
vasoconstriction. Inasmuch as metaboreflex-induced increases in CO and MAP are
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also attenuated in HTN, the ability of the reflex to restore blood flow to ischemic working
muscle is also likely impaired which may contribute to exercise intolerance. Moreover,
coronary vasoconstriction during exercise in HTN may produce adverse cardiovascular
events (e.g., coronary vasospasms, arrhythmias and myocardial ischemia).
The increase in myocardial oxygen demand during submaximal dynamic
exercise is principally met by increases in CBF inasmuch as myocardial oxygen
consumption is highly blood flow dependent since oxygen extraction is already near
maximal at rest (37; 40; 156).

The rise in CBF is largely mediated by coronary

metabolic vasodilation (while ~25% of coronary vasodilation is feed-forward, β2adrenergic-mediated) as there is little increase in MAP (49). At the same time, the rise
in cardiac SNA with exercise limits coronary vasodilation as it activates vascular α1adrenergic receptors inducing a coronary constrictor tone (15; 33; 57; 65; 110; 154).
Gwirtz et al. demonstrated an α1-adrenergic-mediated coronary constrictor tone during
dynamic exercise in normal animals (57) and in animals with renovascular HTN (55).
Moreover, a coronary constrictor tone during exercise has also been shown to attenuate
increases in CBF (56; 57; 65; 84; 110), myocardial oxygen delivery (65), ventricular
function (27; 56; 57; 84) and CO (27; 84). Paradoxically, it has been demonstrated that
this constrictor tone plays a beneficial role in redistributing left-ventricular CBF from the
epicardium to the more metabolically-challenged subendocardium (41; 66). Clearly,
whether or not the presence of a coronary constrictor tone during exercise in normal
individuals is advantageous or merely a cardiac-limiting consequence of elevated SNA
during exercise remains debatable.
Following muscle metaboreflex activation, substantial increases in cardiac SNA,
CO and afterload intensify cardiac work (4; 114; 116; 119; 132; 158; 159; 163). In this
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setting, myocardial oxygen demand is met by increases in CBF which are solely driven
by increases in MAP as no coronary vasodilation is observed (10; 27; 119). In fact,
Coutsos

et

al.

(27)

reported

an

α1-adrenergic-mediated

functional

coronary

vasoconstriction with metaboreflex activation during exercise as metaboreflex-mediated
increases in CVC and CBF markedly improved following α1-adrenergic blockade.
Metaboreflex activation in heart failure, coupled with attenuated coronary vasodilation
due to a decrease in cardiac work, leads to frank coronary vasoconstriction (28).
Therefore, during muscle metaboreflex activation, there is a “push-pull” dynamic for the
control over coronary tone. It is likely that with the increase in cardiac work, coronary
vasodilation is opposed by α1-adrenergic-mediated coronary vasoconstriction.
Is muscle metaboreflex function attenuated in HTN? While few studies have
investigated the effects of HTN on metaboreflex control of cardiovascular function, most
report that its function is accentuated (35; 52; 89; 106; 107; 139; 148) rather than
attenuated (126).

We analyzed the gain (or strength) of metaboreflex-mediated

cardiovascular responses in HTN by determining the slope of the metaboreflex-induced
response line for each parameter we measured. After induction of HTN, the slopes
were significantly lower for all cardiovascular parameters (Figure 4.5) indicating that
metaboreflex function is attenuated in HTN. However, following α1-adrenergic blockade
the slopes of all metaboreflex-induced response lines (except CO; p=0.042) were fully
restored to the levels observed in control experiments following α1-adrenergic blockade.
These data suggest that chronotropic and inotropic function are attenuated during
metaboreflex activation in HTN due to a restriction in CBF stemming from exaggerated
coronary constrictor tone, not an attenuation in metaboreflex function per se nor any
inherent reduction in intrinsic myocardial function (e.g., heart failure).
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While changes in CBF can directly influence ventricular function, changes in
ventricular function can indirectly influence CBF via changes in coronary metabolic
vasodilation. As an increase in perfusion pressure can increase CBF independent of
any change in coronary vasomotor tone (10), the extent of coronary vasodilation can
only

accurately

be

determined

by

calculating

changes

in

conductance

(or

resistance)(113). Feigl and colleagues (49; 50) have shown the utility of quantifying
coronary vasodilation as a function of myocardial oxygen consumption.

As in our

previous studies (27; 28), we used cardiac power (CP) which is well correlated to
myocardial oxygen consumption (81). In normal animals, CVC increased from rest to
exercise and a small further increase occurred with metaboreflex activation similar to
the response observed previously (with exception of the small increase in CVC which
was not statistically significant in our previous study). After induction of HTN, the slope
of the relationship (from free-flow exercise to max) was significantly lower and the
increase in CP was markedly attenuated indicating attenuated myocardial oxygen
delivery as a result of a restrained coronary vasodilation.

Following α1-adrenergic

blockade, the slope of the relationship was significantly shifted upward and not any
different than during α1-adrenergic blockade prior to induction of HTN. Moreover, the
increase in CP was not any different following α1-adrenergic blockade before and after
induction of HTN. The findings demonstrate that attenuation of metaboreflex-induced
increases in CP are largely, if not solely, dependent on heightened α1-adrenergicmediated coronary vasoconstriction in HTN.
The ∆CVC:∆CP relationship was significantly lower after induction of HTN. As
the rise in CP with metaboreflex activation is smaller in HTN, this would tend to increase
∆CVC:∆CP. Therefore, it is clear that the significant decrease in ∆CVC:∆CP following
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induction of HTN is due to a decrease in the rise in CVC with metaboreflex activation.
The ∆CVC:∆CP relationship (from free-flow exercise to max) in HTN was significantly
greater following α1-adrenergic blockade and was not any different than during α1adrenergic blockade prior to induction of HTN. This suggests that the rise in CVC with
metaboreflex activation is markedly restrained in HTN and that this exaggerated
coronary vasoconstriction can be ameliorated following α1-adrenergic blockade.
An increase in CBF can improve ventricular function via an increase in
myocardial oxygen delivery (112).

To analyze the relationship between ventricular

function and coronary perfusion, we plotted dP/dtmax versus CBF (Figure 4.8). This
relationship was exceptionally linear.

After induction of HTN, metaboreflex-induced

increases in both dP/dtmax and CBF were significantly attenuated, without any change in
the slope of the relationship. Following α1-adrenergic blockade, metaboreflex-induced
increases in dP/dtmax and CBF were restored to the same levels following α1-adrenergic
blockade prior to induction of HTN. These data support hypothesis that exaggerated
coronary vasoconstriction in HTN with metaboreflex activation restrains coronary
perfusion thereby limiting myocardial oxygen delivery and increases in ventricular
function. While the highly linear relationship between dP/dtmax and CBF suggests that
ventricular function is intimately dependent on changes in CBF, the fact that the slope of
this relationship did not change after induction of HTN suggests that most, if not all, of
the ventricular impairment observed in this study was solely due to exaggerated
coronary vasoconstriction, not myocardial dysfunction per se.

Coutsos et al. (28)

reported that exaggerated metaboreflex-mediated coronary vasoconstriction attenuates
the rise in CBF and impairs increases in ventricular function in a heart failure model.
Furthermore, they demonstrated that this impairment in ventricular function was partially
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ameliorated following α1-adrenergic blockade.

They concluded that the impaired

ventricular function in heart failure was due to both intrinsic ventricular dysfunction as
well as exaggerated coronary vasoconstriction.
The pathology of HTN is wide-ranging.

Structural and/or functional changes

have been well documented in the heart and the vasculature (122).

Moreover,

alterations in arterial baroreflex (22; 53; 73; 109; 149; 164; 164) and muscle
metaboreflex function (35; 52; 89; 106; 107; 126; 136; 139; 148) as well as brainstem
processing of this reflex information has been demonstrated (53). The attenuation of
chronotropic and inotropic function after induction of HTN observed in the present study
is clearly not due to overt pathology of the heart and the vasculature as α1-adrenergic
blockade fully restored chronotropic and inotropic function to the same levels observed
after α1-adrenergic blockade prior to induction of HTN. The arterial baroreflex buffers
muscle metaboreflex-mediated pressor responses by attenuating its capacity to
increase peripheral resistance by constricting the peripheral vasculature (82; 142).
There are reports of reduced baroreflex function in HTN (73; 109; 149; 164), however,
to the best of our knowledge, there are no studies demonstrating accentuated
baroreflex function.

Therefore, it is unlikely that the attenuated cardiovascular

responses reported in the present study are a result of exaggerated arterial baroreflex
buffering of the muscle metaboreflex. Moreover, Smith et al. (148) demonstrated that
impaired baroreflex function in HTN has little, if any, effect on skeletal muscle reflex
function. Dysfunctional metaboreflex afferent signal processing could at least partially
explain the attenuated reflex-mediated increases in cardiovascular function, however
data suggest that metaboreceptors are actually sensitized in HTN (106). While we did
not study β-adrenergic function in the present study, studies have demonstrated
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impaired cardiac responses potentially stemming from reduced β-adrenergic receptor
function (18; 165) and density (103).
Potential limitations. By chance and availability, all animals in the present study
were female. Data were not collected from animals during estrus. Our group (88) has
shown that in dogs muscle metaboreflex function is not influenced by gender.
Systemic α1-adrenergic blockade can alter loading conditions as it reduces total
peripheral resistance. Gwirtz and colleagues (36; 56; 84) administered prazosin via the
intracoronary route.

However, results from such studies on changes in ventricular

function following α1-adrenergic blockade are limited to the particular segment of the left
ventricle infused with drug. In the present study, we were interested in the effects of α1adrenergic blockade on global left-ventricular function, and therefore we infused
prazosin systemically.

We employed a selective α1-adrenergic blocker, as α2-

adrenergic receptor blockade has negligible effects on coronary vasomotor tone during
exercise (33; 154).

Following α1-adrenergic blockade in normal animals, MAP was

lower at rest, during exercise and during exercise with metaboreflex activation with
respect to control. After induction of HTN in the same animals, MAP was lower at rest
and during exercise with respect to control.

Interestingly, during exercise with

metaboreflex activation, MAP following α1-adrenergic blockade was not any different
than control (likely due to the blunted rise NIVC in HTN). Our hypothesis was that
increases in ventricular function would be impaired due to exaggerated coronary
vasoconstriction during metaboreflex activation in HTN. Therefore, the major potential
concern with systemic prazosin administration would be its effects on our index of
contractility (dP/dtmax) as this measurement is sensitive to loading conditions. However,
while changes in preload can significantly affect dP/dtmax (124), changes in afterload
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have little, if any, direct effect on this parameter (1; 70; 96; 124).
In summary, we found that coronary vasoconstriction in HTN with metaboreflex
activation restrains coronary perfusion and thereby limits myocardial oxygen delivery
and

increases

in

ventricular

function

during

submaximal

dynamic

exercise.

Accentuated coronary vasoconstriction in HTN could partially explain exercise
intolerance and potentially precipitate adverse cardiovascular events during exercise
such as coronary vasospasms, arrhythmias, myocardial ischemia or sudden cardiac
death (64).
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Skeletal muscle ischemia during or immediately following exercise leads to the
accumulation of metabolites (e.g., lactate, proton and diprotonated phosphate) which
activate chemoreceptive afferents within the muscle leading to a reflex increase in
sympathetic outflow generating substantial increases in mean arterial pressure (MAP),
cardiac output (CO) and heart rate (HR) - termed the muscle metaboreflex. When the
reflex is activated during submaximal dynamic exercise, the pressor response occurs
via increased CO with no net peripheral vasoconstriction. When metaboreflex activation
is sustained during the recovery from exercise (i.e., post-exercise muscle ischemia –
(PEMI)), whereas MAP remains elevated for as long as the ischemia is maintained, HR
precipitously declines towards resting levels drawing into question the role of CO in
supporting the pressor response. When the reflex increase in CO is attenuated (e.g., in
heart failure), heightened peripheral vasoconstriction supports the pressor response. In
hypertension (HTN), metaboreflex-mediated increases in ventricular function and CO
are markedly attenuated during mild exercise. As sympathetic nerve activity (SNA) is
exaggerated in both heart failure and HTN, it is plausible that the mechanisms
mediating the attenuation of CO in HTN with muscle metaboreflex activation are similar
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to those previously described in heart failure. Employing a chronically-instrumented
canine model, data were collected from control animals and the same animal after
induction of HTN.

We addressed three specific questions: 1) what are the

mechanism(s) mediating the muscle-metaboreflex-induced pressor response observed
during PEMI in normal subjects, 2) what are the mechanism(s) mediating the musclemetaboreflex-induced pressor response observed during PEMI in hypertensive subjects
and 3) does metaboreflex activation during submaximal exercise in hypertensive
animals functionally restrain coronary vasodilation further limiting increases in
ventricular performance. We found that: 1) the sustained increase in MAP during PEMI
is driven by a sustained increase in CO not peripheral vasoconstriction, 2) the
attenuated pressor response in HTN is not sustained during PEMI as HR and CO fall to
normal recovery levels and 3) in HTN, exaggerated metaborelfex-induced increases in
SNA functionally vasoconstrict the coronary vasculature impairing increases in CBF
which limits oxygen delivery and ventricular performance.
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